Endrikat, J <br/><br/>
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance.  [electronic resource] 

 -  Contraception  Oct 1995 
 - 229-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0010-7824 
<br/><br/><label>Standard No.: </label>10.1016/0010-7824(95)00191-c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Amenorrhea--epidemiology<br/>Austria--epidemiology<br/>Body Weight--physiology<br/>Contraceptives, Oral--adverse effects<br/>Desogestrel--adverse effects<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Drug Tolerance<br/>Dysmenorrhea--epidemiology<br/>Ethinyl Estradiol--adverse effects<br/>Female<br/>France--epidemiology<br/>Headache--epidemiology<br/>Humans<br/>Longitudinal Studies<br/>Menstrual Cycle--drug effects<br/>Nausea--epidemiology<br/>Norpregnenes--adverse effects<br/>Progesterone Congeners--adverse effects<br/>Time Factors